research use only

PKD/PKCμ Antibody [D22N3]

Cat.No.: F3042

    Application: Reactivity:
    • F3042-wb
      Lane 1: LNCaP

    Experiment Essentials

    WB
    Recommended SDS-PAGE separating gel concentration: 5%.

    Usage Information

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Reactivity
    Human, Monkey
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    115 kDa
    Positive Control LNCaP cell
    Negative Control HCT-15 cell; Caki cell; HeLa cell

    Exprimental Methods

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    Biological Description

    Specificity
    PKD/PKCμ Antibody [D22N3] detects endogenous levels of total PKD/PKCμ protein.
    Subcellular Location
    Cell membrane, Cytoplasm, Golgi apparatus, Membrane
    Uniprot ID
    Q15139
    Clone
    D22N3
    Synonym(s)
    Serine/threonine-protein kinase D1; Protein kinase C mu; Protein kinase D; nPKC-D1; nPKC-mu; PRKD1; PKD; PKD1; PRKCM
    Background
    Protein Kinase D (PKD) isoforms, including PKD1 (PKCμ), PKD2, and PKD3, are serine/threonine kinases involved in a variety of cellular processes regulated by PKC-dependent phosphorylation. PKDs have a conserved architecture with an N-terminal regulatory region containing two cysteine-rich C1 domains that bind diacylglycerol (DAG), and a pleckstrin homology (PH) domain, which exerts autoinhibition over their catalytic C-terminal kinase domain. Activation of PKD isoforms requires phosphorylation of two conserved serine residues in the activation loop (Ser744 and Ser748 for PKD1), mainly by PKCs. Additionally, PKD autophosphorylates at the C-terminal serine (Ser916 in PKD1), which correlates with increased catalytic activity. PKD isoforms regulate secretion, gene expression, cell proliferation, Golgi apparatus trafficking, muscle contraction, oxidative stress response, and play roles in signaling pathways related to cardiac hypertrophy, angiogenesis, and cancer progression. Protein kinase D (PKD) regulates cell migration, survival, and chemoresistance in part by phosphorylating class II histone deacetylases (HDACs), thereby modulating the epigenetic control of gene expression. Dysregulation of PKD activity is implicated in pathological conditions such as cancer and cardiovascular diseases.
    References
    • https://pubmed.ncbi.nlm.nih.gov/11943587/
    • https://pubmed.ncbi.nlm.nih.gov/28174535/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.

    Please enter your name.
    Please enter your email. Please enter a valid email address.
    Please write something to us.